TVRD - צמיחת הכנסות משנה לשנה ב-12 החודשים האחרונים Cara Corp

The cancellation of CMS bonuses undermined clinic economics, triggering a sharp customer exodus, as illustrated by this GURU.Markets chart of annual operating sales revenue growth (TTM). The value -100.20 represents the latest metric reading. Cara Therapeutics Inc (TVRD) revenues are based on the sale of Korsuva for dialysis patients, while future growth relies on the safety of new drugs and available capital.
Cara Therapeutics - פילוחים אנליטיים ומדדי מפתח (TVRD)

Amid blocked scalability and program reductions, Cara Therapeutics Inc (TVRD) is losing operational leverage and shifting into a strict capital preservation mode. This LTM revenue growth rate aggregates revenue dynamics over a rolling year, allowing investors to assess the business's actual ability to generate cash flow and withstand inflationary pressure through the analysis of this chart.